Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype

Severe asthma (SA) is categorized into multiple overlapping phenotypes and clinical characteristics driven by complex mechanistic inflammatory pathways. Mepolizumab is a human monoclonal antibody effectively targeting interleukin-5 in severe eosinophilic asthma. However, the eligibility of biologics...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Pérez, Ruperto, Poza-Guedes, Paloma, Mederos-Luis, Elena, Sánchez-Machín, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599709/
https://www.ncbi.nlm.nih.gov/pubmed/36289896
http://dx.doi.org/10.3390/biomedicines10102635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599709/
https://www.ncbi.nlm.nih.gov/pubmed/36289896
http://dx.doi.org/10.3390/biomedicines10102635

Ejemplares similares